share

6-(4-Biphenylyl)-3-Chloro-12,13-Dimethoxy-9,10-Dihydro-7H-Isoquino(2,1-D)(1,4)Benzodiazepine CAS NO 62206-10-4


Unit Price:

CAS No.:62206-10-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

6-(4-Biphenylyl)-3-Chloro-12,13-Dimethoxy-9,10-Dihydro-7H-Isoquino(2,1-D)(1,4)Benzodiazepine is a high-purity, complex heterocyclic organic compound of significant interest in advanced chemical synthesis. This compound serves as a critical pharmacological research intermediate and a versatile building block for the development of novel active molecules. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of specialized benzodiazepine analogs and other bioactive compounds.

Application

  • Pharmaceutical Research & Development: A key synthetic intermediate in the discovery and development of new therapeutic agents, particularly those targeting the central nervous system.
  • Active Pharmaceutical Ingredient (API) Synthesis: Used as a sophisticated precursor in the multi-step synthesis of complex drug candidates and high-value APIs.
  • Biochemical & Medicinal Chemistry Studies: Employed in structure-activity relationship (SAR) studies to explore and optimize biological activity profiles.
  • Reference Standard & Analytical Testing: Serves as a high-purity analytical standard for method development, quality control, and regulatory submissions.
  • Fine Chemical & Specialty Synthesis: A valuable building block for creating novel heterocyclic compounds in academic and industrial research settings.

Basic Information

Product Name 6-(4-Biphenylyl)-3-Chloro-12,13-Dimethoxy-9,10-Dihydro-7H-Isoquino(2,1-D)(1,4)Benzodiazepine
CAS No. 62206-10-4
Molecular Formula C31H25ClN2O2
Molecular Weight 493.00 g/mol
Synonyms 6-(4-Biphenylyl)-3-chloro-12,13-dimethoxy-9,10-dihydro-7H-isoquino[2,1-d][1,4]benzodiazepine; 3-Chloro-6-(4-phenylphenyl)-12,13-dimethoxy-9,10-dihydro-7H-isoquino[2,1-d][1,4]benzodiazepine; 62206-10-4; Isoquino(2,1-d)(1,4)benzodiazepine derivative; Biphenylyl-substituted isoquinobenzodiazepine
EINECS Contact for details

Quality Control

Our 6-(4-Biphenylyl)-3-Chloro-12,13-Dimethoxy-9,10-Dihydro-7H-Isoquino(2,1-D)(1,4)Benzodiazepine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for research and development applications. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. Due to its light-sensitive nature, handling and storage should minimize exposure to direct light.

Specification

Item Specification
Appearance Off-white to light yellow solid
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 97.0%
Related Substances (HPLC) Total impurities ≤ 3.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.